Results recently presented from a study of multiple sclerosis (MS) patients taking TYSABRI (natalizumab) are supported by a Canadian woman’s improved vision since starting the therapy.
No Comments »
Filed under: Pharmacy News
Neptune Technologies & Bioressources Inc. subsidiary, Acasti Pharma Inc., reports the completion of its preclinical program designed to compare the lipid management effects of Acasti’s drug candidate CaPre versus prescription drug Lovaza.
No Comments »
Filed under: Pharmacy News
The Biotechnology Industry Organization (BIO) today announced a specialized workshop on advancements in synthetic biology that will highlight a new effort called the BIOFAB: International Open Facility Advancing Biotechnology, which aims to produce thousands of free, standardized DNA parts. Speakers at the Advancements in Synthetic Biology & BIOFAB workshop will include: - Dr…
No Comments »
Filed under: Pharmacy News
For centuries, intellectuals have met at the ring-stained surfaces of coffee shops to pore over the most pressing problems of the day — but has anyone ever pondered the coffee rings they left behind? What causes the formation of stain patterns left behind by coffee droplets on a surface? You might think coffee ring formation, [...]
No Comments »
Filed under: Pharmacy News
The New York Times: Consumer groups have filed a complaint with the Federal Trade Commission alleging popular health websites are collecting too much information from users, saying that “site visitors who provide personal details about themselves might not be aware that QualityHealth [among other websites] collects information about people’s medical conditions, preferred medici…
No Comments »
Filed under: Pharmacy News
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed in connection with SIMCOR® (niacin/simvastatin) extended-release tablets, 1000/20 mg.
No Comments »
Filed under: Pharmacy News
A team of researchers from Spain and Latin America have synthesized two iron compounds that inhibit the in vitro growth of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Due their low level of toxicity in mammel cells, the compounds could be used in the future as therapeutic agents and hospital disinfectants.
No Comments »
Filed under: Pharmacy News
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
No Comments »
Filed under: Pharmacy News
Millions of cancer patients worldwide may soon be able to receive more effective, personalized treatments for their disease thanks to developments in the understanding of cancer biology, experts will say at the Cancer Biology for Clinicians Symposium organized by the European Society for Medical Oncology (ESMO) in Nice this week.
No Comments »
Filed under: Pharmacy News
“Since the introduction of smallpox vaccination by Sir Edward Jenner in 1796, it took 184 years until the WHO could declare the world free of smallpox. How long will it take to eliminate pneumococcus from the world?”
No Comments »
Filed under: Pharmacy News
